Search results
7 lut 2023 · Prognosis. Polymyositis, being a chronic disease, is associated with a grave prognosis in the long run. In addition to causing disability and affecting the quality of life of the patient, this disease has also been found to be associated with a 10% mortality rate, especially in those who also develop cardiac dysfunction or malignant conditions ...
For dermatomyositis, polymyositis, and necrotizing myopathy, the progression of the disease is more complicated and harder to predict. More than 95 percent of those with DM, PM, and NM are still alive more than five years after diagnosis.
10 sie 2022 · Having this condition can make it difficult to climb stairs, rise from a seated position, lift objects or reach overhead. Polymyositis most commonly affects adults in their 30s, 40s or 50s. Women are affected more often than men. Signs and symptoms usually develop gradually, over weeks or months.
16 sty 2024 · Prognosis for Polymyositis. The prognosis for polymyositis depends on how severe a case you have. Most people respond to treatment and get some of their muscle strength back.
Aim: To analyse the prognostic outcome factors in polymyositis and adult dermatomyositis. Methods: We determined mortality, clinical outcome (muscle strength, disability, persistent use of drugs and quality of life) and disease course and analysed prognostic outcome factors.
5 sie 2024 · What is the life expectancy of someone with polymyositis? Polymyositis won’t usually affect your life expectancy (how long you’ll live). But it can cause fatal complications, especially if it causes severe weakness in your neck and throat muscles.
8 paź 2019 · Polymyositis (PM) and dermatomyositis (DM) are different disease subtypes of idiopathic inflammatory myopathies (IIMs). The main clinical features of PM and DM include progressive symmetric, predominantly proximal muscle weakness.
